Pharmacology, Toxicology and Pharmaceutical Science
Antibody Drug Conjugate
100%
Biological Marker
6%
Bispecific Antibody
6%
Breast Cancer
6%
Cell Surface Marker
6%
Clinical Trial
6%
Colorectal Carcinoma
6%
Epithelium Tumor
6%
Glioblastoma
6%
Immune Checkpoint Inhibitor
6%
Immunotherapy
100%
Lung Cancer
6%
Malignant Neoplasm
100%
Monoclonal Antibody
6%
Preclinical Study
6%
Receptor
6%
Biochemistry, Genetics and Molecular Biology
Antigen Binding
9%
Cancer Stem Cell
100%
CAR T-Cell Therapy
9%
CD133
18%
CD44
18%
Cell Heterogeneity
9%
Cell Surface Marker
9%
Conjugate
100%
Epithelial Cell Adhesion Molecule
18%
Immune Checkpoint Inhibitor
9%
Internalization
9%
Medicine and Dentistry
Biological Marker
9%
Bispecific Antibody
9%
Breast Cancer
9%
Cancer Immunotherapy
100%
Cancer Therapy
9%
CAR T-cell therapy
9%
Clinical Trial
9%
Colorectal Carcinoma
9%
Epithelioma
9%
Glioblastoma
9%
Immune Checkpoint Inhibitor
9%
Immune Evasion
9%
Immunotherapy
9%
Internalization
9%
Lung Cancer
9%
Malignant Neoplasm
9%
Metastatic Carcinoma
9%
Monoclonal Antibody
9%
Programmed Cell Death
9%
Receptor
9%
Immunology and Microbiology
Cancer Immunotherapy
100%
Cancer Stem Cell
100%
Cell Population
9%
Cell Surface Marker
9%
Chimeric Antigen Receptor T-Cell
9%
Immune Evasion
9%
Immunotherapy
9%
Monoclonal Antibody
9%
Preclinical Study
9%
Programmed Cell Death
9%
Material Science
Stem Cell
100%
Surface (Surface Science)
9%
T-Cells
9%
Tumor
9%